STOCK TITAN

Pre-planned stock sales by Phibro (PAHC) CEO-linked entity

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Phibro Animal Health Corp’s CEO-linked entity BFI Co., LLC converted 100,000 shares of Class B Common Stock into 100,000 shares of Class A Common Stock and then sold 21,120 Class A shares in open-market transactions from April 14–16 under a pre-arranged Rule 10b5-1 trading plan adopted on December 11, 2025. Reported weighted average sale prices ranged from about $53.80 to $59.83. After these trades, BFI held 117,000 Class A shares indirectly, while Jack Bendheim also directly held 16,840 Class A shares, showing that a substantial position remains after these planned sales.

Positive

  • None.

Negative

  • None.
Insider BENDHEIM JACK, BFI Co., LLC
Role President and CEO | 10% Owner
Sold 21,120 shs ($1.20M)
Type Security Shares Price Value
Conversion Class B Common Stock 100,000 $0.00 --
Conversion Class A Common Stock 100,000 $0.00 --
Sale Class A Common Stock 5,190 $54.5552 $283K
Sale Class A Common Stock 1,850 $54.8759 $102K
Sale Class A Common Stock 2,623 $56.2691 $148K
Sale Class A Common Stock 3,618 $57.2099 $207K
Sale Class A Common Stock 799 $58.1126 $46K
Sale Class A Common Stock 6,548 $59.0338 $387K
Sale Class A Common Stock 492 $59.6924 $29K
holding Class A Common Stock -- -- --
Holdings After Transaction: Class B Common Stock — 19,496,034 shares (Indirect, See); Class A Common Stock — 124,040 shares (Indirect, See); Class A Common Stock — 16,840 shares (Direct)
Footnotes (1)
  1. The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on December 11, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.61. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6, 7, 9 and 10. The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.63 to $59.83. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.73. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.90 to $57.88. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.92 to $58.22. Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $54.79. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.80 to $54.985. The reported securities are directly held by Jack Bendheim.
Class B to Class A conversion 100,000 shares Class B Common Stock converted into Class A Common Stock
Total shares sold 21,120 shares Class A Common Stock sold in open-market transactions
Sale price example $59.0338 per share Weighted average price for 6,548-share sale on April 14
Highest reported weighted average price $59.83 per share Upper end of disclosed price range in one sale footnote
BFI post-transaction indirect holdings 117,000 shares Class A Common Stock held indirectly after sales
Direct CEO holdings 16,840 shares Class A Common Stock directly held by Jack Bendheim
Rule 10b5-1 plan adoption date December 11, 2025 Date BFI Co., LLC adopted the trading plan
Rule 10b5-1 trading plan regulatory
"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Class B Common Stock financial
"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Class A Common Stock financial
"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
pecuniary interest financial
"Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BENDHEIM JACK

(Last)(First)(Middle)
300 FRANK W. BURR BLVD., STE 21

(Street)
TEANECK NEW JERSEY 07666

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock04/14/2026S(1)6,548D$59.0338(2)31,572ISee(3)
Class A Common Stock04/14/2026S(1)492D$59.6924(4)31,080ISee(3)
Class A Common Stock04/15/2026S(1)2,623D$56.2691(5)28,457ISee(3)
Class A Common Stock04/15/2026S(1)3,618D$57.2099(6)24,839ISee(3)
Class A Common Stock04/15/2026S(1)799D$58.1126(7)24,040ISee(3)
Class A Common Stock04/16/2026C(8)100,000A$0124,040ISee(3)
Class A Common Stock04/16/2026S(1)5,190D$54.5552(9)118,850ISee(3)
Class A Common Stock04/16/2026S(1)1,850D$54.8759(10)117,000ISee(3)
Class A Common Stock16,840D(11)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock$004/16/2026C100,000 (8) (8)Class A Common Stock100,000$019,496,034ISee(3)
1. Name and Address of Reporting Person*
BENDHEIM JACK

(Last)(First)(Middle)
300 FRANK W. BURR BLVD., STE 21

(Street)
TEANECK NEW JERSEY 07666

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
1. Name and Address of Reporting Person*
BFI Co., LLC

(Last)(First)(Middle)
300 FRANK W. BURR BLVD., STE 21

(Street)
TEANECK NEW JERSEY 07666

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on December 11, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.61. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6, 7, 9 and 10.
3. The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.63 to $59.83.
5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.73.
6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.90 to $57.88.
7. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.92 to $58.22.
8. Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date.
9. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $54.79.
10. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.80 to $54.985.
11. The reported securities are directly held by Jack Bendheim.
/s/ Judith Weinstein, as Attorney-in-Fact for Jack Bendheim04/16/2026
/s/ Judith Weinstein, as Attorney-in-Fact for BFI Co., LLC04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did PAHC report for Jack Bendheim and BFI Co., LLC?

A BFI Co., LLC entity linked to PAHC CEO Jack Bendheim converted 100,000 Class B shares into Class A and sold 21,120 Class A shares in open-market trades. These transactions occurred between April 14 and April 16 under a disclosed Rule 10b5-1 plan.

How many Phibro (PAHC) shares were sold in this Form 4 filing?

The filing reports open-market sales totaling 21,120 shares of PAHC Class A Common Stock. These trades were executed over several transactions at weighted average prices mainly between about $53.80 and $59.83, all under a pre-arranged Rule 10b5-1 trading plan.

What share conversion was disclosed for Phibro (PAHC) in this insider report?

The insider report shows a conversion of 100,000 shares of PAHC Class B Common Stock into 100,000 shares of Class A Common Stock. The conversion price is listed as $0.0000, and the Class B shares are convertible into Class A on a one-for-one basis with no expiration.

Were the PAHC insider sales made under a Rule 10b5-1 trading plan?

Yes. The footnotes state the reported sales were effected under a Rule 10b5-1 trading plan adopted by BFI Co., LLC on December 11, 2025. Such plans pre-schedule trades, indicating these sales were planned in advance rather than timed discretionarily.

Who actually holds the PAHC shares involved in these transactions?

The reported securities from the main transactions are directly held by BFI Co., LLC, over which Jack Bendheim exercises voting and dispositive power. A footnote explains he may be deemed to share voting and investment power but disclaims beneficial ownership beyond his pecuniary interest.

How many PAHC shares does the CEO-linked entity hold after these trades?

After the reported sales, BFI Co., LLC held 117,000 shares of PAHC Class A Common Stock indirectly. A separate holding line shows Jack Bendheim directly held 16,840 Class A shares, indicating both indirect and direct positions remain following the transactions.